Journal article icon

Journal article

The 1000 + mouse project for large-scale spatiotemporal parametrization and modeling of preclinical cancer immunotherapies

Abstract:
Preclinical studies of chimeric antigen receptor (CAR)-T cell immunotherapies are often based on monitoring bioluminescent tumors implanted in mice to assess anti-tumor cytotoxicity. Here, we introduce maRQup (murine automatic Radiance Quantification and parametrization), an easy-to-use method that automatically processes bioluminescent tumor images for quantitative analysis. We demonstrate the ability of maRQup to analyze CAR-T cell treatments over >1000 tumor-bearing mice. We compare CD19-targeting CAR-T cells comprising either a CD28 or a 4-1BB costimulatory domain, and found the former controlled the tumor burden better initially, while the latter reduced the frequency of tumor relapse. We also applied maRQup to demonstrate faster tumor growth during the initial growth phase as compared to the relapse phase and to spatiotemporally analyze the high variability in immunotherapeutic control of tumors, based on their anatomical location. maRQup provides quantitative and statistically-robust insights on preclinical experiments that will contribute to the optimization of immunotherapies.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.7554/elife.106470

Authors

More by this author
Institution:
University of Oxford
Role:
Author


Publisher:
eLife Sciences Publications
Journal:
eLife More from this journal
Volume:
14
Article number:
RP106470
Publication date:
2026-03-24
DOI:
EISSN:
2050-084X
ISSN:
2050-084X


Language:
English
Keywords:
Pubs id:
2399976
Local pid:
pubs:2399976
Source identifiers:
3883083
Deposit date:
2026-03-25
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP